Paul Damon & Associates »

AstraZeneca shares owned by Paul Damon & Associates

Quarter-by-quarter ownership of AstraZeneca shares owned by Paul Damon & Associates from 13F filings

Historical chart of Paul Damon & Associates investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Paul Damon & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Paul Damon & Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $400k 4.4k 91.93

More positions owned by Paul Damon & Associates

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Apple (AAPL)
Ishares Tr Core S&p Us Vlu (IUSV)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
First Tr Exchange-traded SHS (FVD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
Microsoft Corporation (MSFT)

View all positions for Paul Damon & Associates

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
FMR
Fisher Investments
Franklin Resources
Capital Research and Management Company - Division 3
Goldman Sachs Group
Sanders Capital
Atlantic Trust
Dimensional Fund Advisors
BlackRock
Ameriprise Financial
Arrowstreet Capital, Limited Partnership
Citadel Advisors
Neuberger Berman Group

View all funds holding AstraZeneca